Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5892) 5892
Book Review (1411) 1411
Publication (289) 289
Book / eBook (53) 53
Book Chapter (44) 44
Magazine Article (25) 25
Newspaper Article (25) 25
Conference Proceeding (19) 19
Trade Publication Article (10) 10
Newsletter (8) 8
Web Resource (4) 4
Dissertation (3) 3
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5299) 5299
humans (4722) 4722
ultraviolet rays - adverse effects (2217) 2217
female (2123) 2123
male (1997) 1997
dermatology (1789) 1789
adult (1529) 1529
middle aged (1305) 1305
animals (1245) 1245
ultraviolet rays (1037) 1037
ultraviolet radiation (906) 906
skin (821) 821
aged (806) 806
mice (650) 650
skin - radiation effects (641) 641
treatment outcome (620) 620
phototherapy (595) 595
psoriasis (545) 545
adolescent (543) 543
skin neoplasms - etiology (534) 534
ultraviolet therapy - adverse effects (524) 524
cancer (507) 507
ultraviolet therapy (482) 482
risk factors (477) 477
radiation (467) 467
skin cancer (462) 462
care and treatment (442) 442
biochemistry & molecular biology (438) 438
therapy (391) 391
analysis (390) 390
psoriasis - drug therapy (385) 385
sunlight - adverse effects (384) 384
ultraviolet therapy - methods (372) 372
pharmacology & pharmacy (362) 362
skin - pathology (361) 361
ultraviolet-radiation (358) 358
abridged index medicus (354) 354
health aspects (347) 347
child (339) 339
photochemotherapy (335) 335
time factors (331) 331
young adult (331) 331
spectrophotometry, ultraviolet (329) 329
melanoma (323) 323
research (314) 314
apoptosis (296) 296
skin - drug effects (294) 294
skin neoplasms - prevention & control (293) 293
light (290) 290
cell biology (281) 281
biophysics (277) 277
administration, topical (276) 276
dna damage (269) 269
ophthalmology (268) 268
skin neoplasms - pathology (266) 266
ultraviolet (261) 261
oncology (259) 259
dermatology & venereal diseases (258) 258
surgery (254) 254
skin - metabolism (253) 253
psoriasis - therapy (251) 251
combined modality therapy (242) 242
puva therapy - adverse effects (238) 238
oxidative stress (237) 237
prospective studies (236) 236
risk (233) 233
psoriasis - radiotherapy (230) 230
prevention (229) 229
dose-response relationship, radiation (223) 223
erythema - etiology (223) 223
u.v. radiation (223) 223
irradiation (222) 222
follow-up studies (221) 221
in-vitro (219) 219
article (217) 217
cells (209) 209
expression (207) 207
skin-cancer (204) 204
sunlight (201) 201
aged, 80 and over (199) 199
skin neoplasms - epidemiology (198) 198
inflammation (194) 194
exposure (191) 191
integumentary system (190) 190
vitamin d (190) 190
in-vivo (185) 185
medicine & public health (184) 184
retrospective studies (182) 182
collagen (179) 179
antioxidants (178) 178
efficacy (178) 178
photosensitizing agents - therapeutic use (178) 178
puva (177) 177
vitiligo (177) 177
mice, hairless (176) 176
uvb (176) 176
severity of illness index (174) 174
medicine (170) 170
skin diseases (170) 170
usage (169) 169
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (35) 35
Engineering & Comp. Sci. - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
UofT at Mississauga - Stacks (3) 3
Online Resources - Online (2) 2
Astronomy & Astrophysics - Ask at library (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Robarts - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5692) 5692
German (141) 141
French (64) 64
Russian (46) 46
Spanish (19) 19
Polish (16) 16
Dutch (12) 12
Italian (7) 7
Finnish (6) 6
Japanese (6) 6
Danish (5) 5
Norwegian (5) 5
Chinese (4) 4
Croatian (4) 4
Czech (3) 3
Hungarian (3) 3
Romanian (3) 3
Hebrew (2) 2
Portuguese (2) 2
Swedish (2) 2
Korean (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text European S3-guidelines on the systemic treatment of psoriasis vulgaris
by Pathirana, D and Ormerod, A.D and Saiag, P and Smith, C and Spuls, P.I and Nast, A and Barker, J and Bos, J.D and Burmester, G.R and Chimenti, S and Dubertret, L and Eberlein, B and Erdmann, R and Ferguson, J and Girolomoni, G and Gisondi, P and Giunta, A and Griffiths, C and Honigsmann, H and Hussain, M and Jobling, R and Karvonen, S.L and Kemeny, L and Kopp, I and Leonardi, C and Maccarone, M and Menter, A and Mrowietz, U and Naldi, L and Nijsten, T and Ortonne, J.P and Orzechowski, H.D and Rantanen, T and Reich, K and Reytan, N and Richards, H and Thio, H.B and Kerkhof, P.C.M. van de and Rzany, B
JEADV : Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 2009, Volume 23, Issue 2, pp. 1 - 70
Of the 131 studies on monotherapy or combination therapy assessed, 56 studies on the different forms of phototherapy fulfilled the criteria for inclusion in... 
FUMARIC-ACID ESTERS | TO-SEVERE PSORIASIS | TUMOR-NECROSIS-FACTOR | CHRONIC PLAQUE PSORIASIS | LONG-TERM SAFETY | 308-NM EXCIMER-LASER | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | CONTROLLED PHASE-III | BAND ULTRAVIOLET-B | DERMATOLOGY | PUVA Therapy - adverse effects | Psoriasis - drug therapy | Recombinant Fusion Proteins - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - adverse effects | Immunoglobulin G - therapeutic use | Antibodies, Monoclonal - therapeutic use | Dermatologic Agents - therapeutic use | Methotrexate - therapeutic use | Dermatologic Agents - adverse effects | Immunoglobulin G - adverse effects | Receptors, Tumor Necrosis Factor - therapeutic use | Antibodies, Monoclonal, Humanized | Cyclosporine - therapeutic use | Methotrexate - adverse effects | Retinoids - therapeutic use | Etanercept | Infliximab | Cyclosporine - adverse effects | Retinoids - adverse effects | Adalimumab | Practice guidelines (Medicine) | Dermatologic agents | Psoriasis | Drug therapy | Dermatology | Formulae, receipts, prescriptions | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time
by Wernli, Jeremy and Schumacher, Silvia and Spoerl, Eberhard and Mrochen, Michael
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 02/2013, Volume 54, Issue 2, pp. 1176 - 1180
PURPOSE. Standard treatment in cases of progressive keratectasia is UV-triggered corneal cross-linking. For irradiances larger than 10 mW/cm(2) and treatment... 
RIBOFLAVIN | ECTASIA | BIOMECHANICAL CHANGES | COLLAGEN | OPHTHALMOLOGY | ULTRAVIOLET | A/RIBOFLAVIN | KERATOCONUS | Corneal Diseases - therapy | Epithelium, Corneal - radiation effects | Cross-Linking Reagents - pharmacology | Riboflavin - pharmacology | Random Allocation | Epithelium, Corneal - pathology | Ultraviolet Therapy - methods | Dilatation, Pathologic - pathology | Photosensitizing Agents - pharmacology | Animals | Biomechanical Phenomena - radiation effects | Time Factors | Swine | Biomechanical Phenomena - drug effects | Dilatation, Pathologic - therapy | Epithelium, Corneal - drug effects | Ultraviolet Therapy - adverse effects | Corneal Diseases - pathology | Dose-Response Relationship, Radiation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cross‐sectional evaluation of acute adverse reactions during ultraviolet A1 phototherapy
by Richer, V and Lui, H
British Journal of Dermatology, ISSN 0007-0963, 07/2017, Volume 177, Issue 1, pp. 258 - 259
DERMATOLOGY | Erythema - etiology | Cross-Sectional Studies | Skin - radiation effects | Humans | Ultraviolet Therapy - adverse effects | Pruritus - etiology | Scleroderma, Localized - radiotherapy | Photosensitivity Disorders - etiology | Analysis | Phototherapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Platelet‐rich plasma: Potential role in combined therapy for vitiligo
by Shih, Shawn
Dermatologic Therapy, ISSN 1396-0296, 01/2019, Volume 32, Issue 1, pp. e12773 - n/a
BAND-ULTRAVIOLET-B | CARBON-DIOXIDE LASER | DERMATOLOGY | Low-Level Light Therapy - adverse effects | Vitiligo - diagnosis | Vitiligo - therapy | Humans | Treatment Outcome | Combined Modality Therapy | Dermatologic Agents - therapeutic use | Dermatologic Agents - adverse effects | Vitiligo - physiopathology | Lasers, Gas - adverse effects | Lasers, Gas - therapeutic use | Time Factors | Low-Level Light Therapy - instrumentation | Skin Pigmentation | Ultraviolet Therapy - adverse effects | Platelet-Rich Plasma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The risk of melanoma and hematologic cancers in patients with psoriasis
by Reddy, Shivani P., BS and Martires, Kathryn, MD and Wu, Jashin J., MD
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 76, Issue 4, pp. 639 - 647.e2
Background The risk of melanoma and hematologic cancers in patients with psoriasis is controversial. Objective We sought to assess the risk of melanoma and... 
Dermatology | malignancy | psoriasis | biologic | melanoma | phototherapy | hematologic cancer | topical therapy | RHEUMATOID-ARTHRITIS | LONG-TERM | MALIGNANT-MELANOMA | METHOTREXATE THERAPY | DERMATOLOGY | LYMPHOMA RISK | TUMOR-NECROSIS-FACTOR | PUVA | POPULATION-BASED COHORT | SKIN-CANCER | Melanoma - epidemiology | PUVA Therapy - adverse effects | Melanoma - etiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Neoplasms, Radiation-Induced - etiology | Male | Risk | Dermatologic Agents - therapeutic use | Hematologic Neoplasms - epidemiology | Dermatologic Agents - adverse effects | Case-Control Studies | Biological Products - adverse effects | Female | Retrospective Studies | Biological Products - therapeutic use | Psoriasis - drug therapy | Comorbidity | California - epidemiology | Proportional Hazards Models | Psoriasis - radiotherapy | Skin Neoplasms - epidemiology | Hematologic Neoplasms - etiology | Psoriasis - epidemiology | Survival Analysis | Ultraviolet Therapy - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Skin Neoplasms - etiology | Immunocompromised Host | Neoplasms, Radiation-Induced - epidemiology | Health maintenance organizations | Medical colleges | Care and treatment | Cancer patients | Psoriasis | Melanoma | Pharmaceutical industry | Cancer | Rheumatoid factor | Formulae, receipts, prescriptions | Dermatologic agents | Phototherapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: A 30-year prospective study
by Stern, Robert S., MD and PUVA Follow-Up Study
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2011, Volume 66, Issue 4, pp. 553 - 562
Background By 1977, psoralen and ultraviolet A (PUVA) was established as a highly effective therapy for psoriasis. Because of concerns about potential... 
Dermatology | psoralen plus ultraviolet A | squamous cell cancer | risk factors | cohort study | basal cell cancer | binomial regression | psoriasis | Cox proportional hazard | prospective | EUROPEAN PUVA | PERSISTENT | A RADIATION PUVA | LIGHT | SEVERE PSORIASIS | FOLLOW-UP | DERMATOLOGY | ORAL METHOXSALEN PHOTOCHEMOTHERAPY | NONMELANOMA SKIN-CANCER | SUN EXPOSURE | CARCINOMA | PUVA Therapy - adverse effects | Prospective Studies | Psoriasis - drug therapy | Time Factors | Carcinoma, Basal Cell - chemically induced | Humans | Risk Factors | Adult | Female | Male | Skin Neoplasms - chemically induced | Neoplasms, Basal Cell - chemically induced | Care and treatment | Squamous cell carcinoma | Basal cell carcinoma | Psoriasis | Oncology, Experimental | Melanoma | Coumarins | Dermatologic agents | Research | Skin cancer | Formulae, receipts, prescriptions | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Afamelanotide and Narrowband UV-B Phototherapy for the Treatment of Vitiligo: A Randomized Multicenter Trial
by Lim, Henry W and Grimes, Pearl E and Agbai, Oma and Hamzavi, Iltefat and Henderson, Marsha and Haddican, Madelaine and Linkner, Rita V and Lebwohl, Mark
JAMA Dermatology, ISSN 2168-6068, 01/2015, Volume 151, Issue 1, pp. 42 - 50
IMPORTANCE: Narrowband UV-B (NB–UV-B) phototherapy is used extensively to treat vitiligo. Afamelanotide, an analogue of α–melanocyte-stimulating hormone, is... 
PATHOGENESIS | SYSTEM | ALPHA-MSH | PEPTIDES | MELANOCYTE-STIMULATING HORMONE | ANALOG | ERYTHROPOIETIC PROTOPORPHYRIA | MELANOCORTIN-1 RECEPTOR | EXPRESSION | INSIGHTS | DERMATOLOGY | Vitiligo - therapy | Follow-Up Studies | Humans | Middle Aged | Drug Implants | Male | Treatment Outcome | alpha-MSH - adverse effects | Combined Modality Therapy | alpha-MSH - therapeutic use | Disease Progression | Ultraviolet Therapy - methods | Young Adult | Vitiligo - pathology | Adolescent | Ultraviolet Therapy - adverse effects | Adult | Female | Aged | alpha-MSH - analogs & derivatives | Vitiligo | Care and treatment | Usage | Drug therapy, Combination | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population
by Asgari, Maryam M., MD, MPH and Ray, G. Thomas, MBA and Geier, Jamie L., PhD and Quesenberry, Charles P., PhD
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 76, Issue 4, pp. 632 - 638
Background Moderate to severe psoriasis often requires treatment with systemic agents, many of which have immunosuppressive properties and could increase... 
Dermatology | epidemiology | biologics | psoriasis | nonmelanoma skin cancer | basal cell carcinoma | cancer | cutaneous squamous cell carcinoma | tumor necrosis factor-alfa | Basal cell carcinoma | Cutaneous squamous cell carcinoma | Tumor necrosis factor-alfa | Psoriasis | Nonmelanoma skin cancer | Biologics | Epidemiology | Cancer | RHEUMATOID-ARTHRITIS | METAANALYSIS | ADALIMUMAB | RISK | PREVALENCE | DERMATOLOGY | THERAPY | NONMELANOMA SKIN-CANCER | TNF-ALPHA | SQUAMOUS-CELL CARCINOMAS | ETANERCEPT | Neoplasms - etiology | Age Factors | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Neoplasms, Radiation-Induced - etiology | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Dermatologic Agents - therapeutic use | Dermatologic Agents - adverse effects | Incidence | Young Adult | Adult | Female | Psoriasis - drug therapy | Carcinoma, Squamous Cell - epidemiology | Comorbidity | California - epidemiology | Proportional Hazards Models | Psoriasis - radiotherapy | Skin Neoplasms - epidemiology | Managed Care Programs | Psoriasis - epidemiology | Carcinoma, Squamous Cell - etiology | Confounding Factors (Epidemiology) | Ultraviolet Therapy - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Skin Neoplasms - etiology | Immunocompromised Host | Neoplasms, Radiation-Induced - epidemiology | Neoplasms - epidemiology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Health maintenance organizations | Managed care plans (Medical care) | Oncology, Experimental | Melanoma | Health care industry | Skin | Research | Skin cancer | Squamous cell carcinoma | Formulae, receipts, prescriptions | Dermatologic agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo
by Mohammad, Tasneem F., MD and Al-Jamal, Mohammed, MD and Hamzavi, Iltefat H., MD and Harris, John E., MD, PhD and Leone, Giovanni, MD and Cabrera, Raúl, MD and Lim, Henry W., MD and Pandya, Amit G., MD and Esmat, Samia M., MD
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2017, Volume 76, Issue 5, pp. 879 - 888
Background Treatment of vitiligo with narrowband ultraviolet B light (NBUVB) is an important component of the current standard of care. However, there are no... 
Dermatology | UVB | narrowband phototherapy | vitiligo | pigmentation | expert recommendation | UVB PHOTOTHERAPY | RISK | RADIATION | DERMATOLOGY | MELANOMA | THERAPY | NONMELANOMA SKIN-CANCER | FREQUENCY | 308-NM EXCIMER-LASER | COHORT | PSORIASIS | Radiotherapy Dosage - standards | Humans | Ultraviolet Therapy - standards | Vitiligo - radiotherapy | Ultraviolet Therapy - adverse effects | Chemotherapy, Adjuvant | Consensus | Practice Guidelines as Topic | Ultraviolet Therapy - methods | Medical colleges | Phototherapy | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Azathioprine treatment photosensitizes human skin to ultraviolet A radiation
by Perrett, C.M and Walker, S.L and ODonovan, P and Warwick, J and Harwood, C.A and Karran, P and McGregor, J.M
British Journal of Dermatology, ISSN 0007-0963, 07/2008, Volume 159, Issue 1, pp. 198 - 204
Summary Background  Azathioprine is used to treat a variety of conditions and to prevent graft rejection in organ transplant recipients (OTRs). Objectives  To... 
UVB | UVA | reduction in MED | SSR | 6-thioguanine | 6‐thioguanine | Reduction in MED | IRRADIATED INSITU | OXIDATIVE DNA-DAMAGE | REPAIR ENZYME | LIGHT | INDUCTION | CANCER | DERMATOLOGY | PYRIMIDINE DIMER FORMATION | XERODERMA-PIGMENTOSUM | CELLULAR-DNA | WAVELENGTH DEPENDENCE | Graft Rejection - drug therapy | Epidermis - radiation effects | Photosensitivity Disorders - chemically induced | Humans | Middle Aged | Male | Treatment Outcome | Case-Control Studies | Thioguanine - adverse effects | Ultraviolet Therapy - adverse effects | Adult | Female | Immunosuppressive Agents - adverse effects | Skin Neoplasms - etiology | DNA Damage | Azathioprine - adverse effects | Dose-Response Relationship, Radiation | Research institutes | Azathioprine | Radiation | Skin care products | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Influence of dermal exposure to ultraviolet radiation and coal tar (polycyclic aromatic hydrocarbons) on the skin aging process
by Borska, Lenka and Andrys, Ctirad and Krejsek, Jan and Palicka, Vladimir and Vorisek, Viktor and Hamakova, Kvetoslava and Kremlacek, Jan and Borsky, Pavel and Fiala, Zdenek
Journal of Dermatological Science, ISSN 0923-1811, 2015, Volume 81, Issue 3, pp. 192 - 202
Highlights • We evaluate the Goeckerman therapy (GT) of psoriasis for skin aging process. • GT combines UV radiation and coal tar with polycyclic aromatic... 
Dermatology | UV radiation | Chromosomal aberration | 25-Hydroxy vitamin D | Oxidative stress | Polycyclic aromatic hydrocarbons | VITAMIN-D | OXIDATIVE DNA-DAMAGE | SUN | GOECKERMAN REGIMEN | CELL-DEATH | DERMATOLOGY | BIOMARKERS | GENOTOXICITY | 1-HYDROXYPYRENE | NARROW-BAND | STRESS | Smoking - adverse effects | Whole-Body Irradiation | Biomarkers - urine | Humans | Middle Aged | Psoriasis - diagnosis | Skin Aging - radiation effects | Male | Administration, Cutaneous | RNA Stability - drug effects | Polycyclic Aromatic Hydrocarbons - administration & dosage | Coal Tar - administration & dosage | Young Adult | Polycyclic Aromatic Hydrocarbons - adverse effects | Time Factors | Psoriasis - metabolism | Adult | Female | Keratolytic Agents - administration & dosage | Oxidative Stress - radiation effects | Psoriasis - therapy | Pyrenes - urine | Skin Aging - drug effects | Keratolytic Agents - adverse effects | Treatment Outcome | Combined Modality Therapy | Biomarkers - blood | Coal Tar - adverse effects | Ultraviolet Therapy - methods | Vitamin D - blood | Ultraviolet Therapy - adverse effects | Vitamin D - analogs & derivatives | Aged | DNA Damage | Oxidative Stress - drug effects | RNA Stability - radiation effects | Chronic Disease | Care and treatment | Ultraviolet radiation | Psoriasis | Vitamin D | Calcifediol | Skin | Alfacalcidol | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half‐body, comparative study
by Li, Lu and Wu, Yan and Li, Li and Sun, Yan and Qiu, Li and Gao, Xing‐Hua and Chen, Hong‐Duo
Dermatologic Therapy, ISSN 1396-0296, 05/2015, Volume 28, Issue 3, pp. 131 - 134
Vitiligo on extremities and/or bony prominences is very resistant to treatment. Twenty‐five patients with symmetrical and stable vitiligo on extremities and/or... 
laser | therapy‐topical | vitiligo | NONSEGMENTAL VITILIGO | therapy-topical | CREAM | DERMATOLOGY | Glucocorticoids - administration & dosage | Vitiligo - diagnosis | Prospective Studies | Betamethasone - administration & dosage | Humans | Middle Aged | Male | Administration, Cutaneous | Pharmaceutical Solutions | Patient Satisfaction | Young Adult | Lasers, Gas - adverse effects | Lasers, Gas - therapeutic use | Time Factors | Skin Pigmentation - radiation effects | Adult | Female | Betamethasone - adverse effects | Glucocorticoids - adverse effects | Vitiligo - therapy | Treatment Outcome | Combined Modality Therapy | Vitiligo - physiopathology | Skin Pigmentation - drug effects | Ultraviolet Therapy - adverse effects | Comparative analysis | Corticosteroids | Phototherapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights